Provexis PLC
F:NZCA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Provexis PLC
F:NZCA
|
UK |
|
N
|
Nortec Minerals Corp
OTC:NMNZF
|
CA |
|
Calliditas Therapeutics AB
F:LC8
|
SE |
|
F
|
Friwo AG
SWB:CEA
|
DE |
|
Sultan Resources Ltd
OTC:SLZRF
|
AU |
|
C
|
Calidus Resources Ltd
OTC:CALRF
|
AU |
|
Nipro Corp
OTC:NPRRF
|
JP |
|
Cybin Inc
F:R7E
|
CA |
|
Automotive Finco Corp
OTC:RMIAF
|
CA |
|
T
|
TG Therapeutics Inc
SWB:NKB2
|
US |
|
T
|
TG Therapeutics Inc
F:NKB2
|
US |
|
Illumina Inc
NASDAQ:ILMN
|
US |
Multiples-Based Value
The Multiples-Based Value for
Provexis PLC (NZCA) under the Base Case is hidden
EUR.
Compared with the current market price of 0.009 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.